Drugs Made In America Acquisition II Corp. appoints Saleem Elmasri as CFO after Glenn Worman resigns

Drugs Made In America Acquisition II Corp.

Glenn Worman resigned as CFO and principal financial and accounting officer effective October 8, 2025, with no disagreement with the company.
Saleem Elmasri was appointed CFO effective November 17, 2025, under a consulting agreement with Titan Advisory Services LLC.
Compensation includes $42,000 per year ($3,500 per month) plus 100,000 ordinary shares transferred by CEO Lynn Stockwell.
Elmasri is a CPA with 20 years experience, previously at PwC and as Managing Partner of Titan Advisory Services LLC since 2020.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.